Drugs like Ozempic and Wegovy—also known as glucagon-like peptide-1 (GLP-1) or semaglutide medications—have been linked to increased suicidal thoughts, says a new study published in JAMA Network Open on Aug. 20.
“A detected signal of semaglutide-associated suicidal ideation warrants urgent clarification,” the academic researchers noted in the study.
